Crow Point Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,000
Closed -$340K 126
2018
Q3
$340K Buy
+2,000
New +$337K 0.06% 103
2018
Q2
Sell
-2,839
Closed -$459K 152
2018
Q1
$459K Hold
2,839
0.08% 72
2017
Q4
$415K Sell
2,839
-3,070
-52% -$437K 0.07% 101
2017
Q3
$803K Buy
5,909
+519
+10% +$65.6K 0.13% 70
2017
Q2
$674K Buy
5,390
+385
+8% +$46K 0.11% 75
2017
Q1
$595K Sell
5,005
-122,689
-96% -$14.8M 0.09% 87
2016
Q4
$14.7M Buy
+127,694
New +$14.2M 2.4% 17

Other funds holding CME

Crow Point Partners's CME Position: Q4 2018 in Review

Crow Point Partners sold out of CME Group (CME) in Q4 2018, closing a stake of 2,000 shares — an estimated $340K sold.

Crow Point Partners first reported a position in CME in Q4 2016 and held it in 7 quarters. The position peaked at $14.7M in Q4 2016. 1,014 funds tracked by Wall St. Rank hold CME as of Q4 2018.

  • Crow Point Partners reported no remaining CME Group position as of Q4 2018 after selling out during the quarter.
  • Crow Point Partners sold 2,000 CME Group shares in Q4 2018, an estimated $340K.
  • Crow Point Partners first reported a position in CME Group in Q4 2016 and held it in 7 quarters.
  • Crow Point Partners's CME Group position peaked at $14.7M in Q4 2016.
  • 1,014 funds tracked by Wall St. Rank held CME Group as of Q4 2018.

Based on Crow Point Partners's 13F filing for Q4 2018, filed 14 Feb 2019.